Patent US4591496A successfully refreshed from Google Patents.
US4591496A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for making systems for the controlled release of macromolecules
Assignee: Massachusetts Institute of Technology
•
Filing: 1984-01-16
•
Granted: 1986-05-27
•
Expires: 2004-01-16
Abstract
Abstract A new method for making polymeric systems for the sustained release of macromolecular drugs is described. The method consists of mixing drug and polymer, e.g. ethylene-vinyl acetate copolymer powders below the glass transition temperature of the polymer, and compressing the mixture at a temperature above the glass transition point. The macromolecule is not exposed to organic solvent during the fabrication process. The sustained release and bioactivity of macromolecules is unchanged throughout the pressure casting and release processes.
Inventors
- 👤 Jonathan M. Cohen
- 👤 Ronald Siegel
- 👤 Robert Langer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:55
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2027
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
145 words
A method for making a glass-like matrix useful as a delivery system for the controlled release of biologically active substances comprising the steps of: preparing a polymeric material in powder form at a temperature below its glass transition temperature, said polymeric material having limited water sorptivity; preparing a swellable biologically active substance in powder form at a temperature less than the minimal temperature at which substantial degradation of the substance occurs; combining said polymeric material powder and said biologically active substance powder as a mixture in ratios ranging from 97-10 parts polymeric material powder by weight to 3-90 parts biologically active substance powder by weight; and compressing said mixture to form a solid, glass-like matrix, said compression occurring at a temperature greater than the glass transition temperature of said polymeric material but less than the minimal temperature for substantial degradation of said biologically active substance.
Claim 2
Independent Claim
145 words
A method for making a glass-like matrix useful as a delivery system for the controlled release of biologically active substances comprising the steps of: preparing a polymeric material in powder form at a temperature below its glass transition temperature, said polymeric material having limited water sorptivity; preparing a swellable biologically active substance in powder form at a temperature less than the minimal temperature at which substantial degradation of the substance occurs; combining said polymeric material powder and said biologically active substance powder as a mixture in ratios ranging from 97-10 parts polymeric material powder by weight to 3-90 parts biologically active substance powder by weight; and compressing said mixture to form a solid, glass-like matrix, said compression occurring at a temperature greater than the glass transition temperature of said polymeric material but less than the minimal temperature for substantial degradation of said biologically active substance.
Claim 3
Dependent Claim
49 words
In the method of claim 1, the improvement wherein said polymer is an ethylene-vinyl ester copolymer of the general formula ##STR3## wherein R is hydrogen, lower alkyl of 1 to 7 carbons, or aryl, m is (10 to 40) % by weight and n is (100-m) % by weight.
Claim 4
Dependent Claim
16 words
In the method of claim 1, the improvement wherein said biologically active substance is an enzyme.
Claim 5
Dependent Claim
16 words
In the method of claim 1, the improvement wherein said biologically active substance is a hormone.
Claim 6
Dependent Claim
17 words
In the method of claim 1, the improvement wherein said biologically active substance is an enzyme inhibitor.
Claim 7
Dependent Claim
16 words
In the method of claim 1, the improvement wherein said biologically active substance is an antigen.
Claim 8
Dependent Claim
16 words
In the method of claim 1, the improvement wherein said biologically active substance is a drug.
References Cited (Backward Citations)
US2757124A
Cited
US3096248A
Cited
US3308217A
Cited
US3670065A
Cited
US4179497A
Cited
US4151273A
Cited
US4164560A
Cited
US4357312A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1989-05-26 | 1989-11-25 | 1990-05-27 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1993-05-26 | 1993-11-25 | 1994-05-27 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1997-05-26 | 1997-11-25 | 1998-05-27 | $7700.00 | Window Closed / Lapsed |